Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Raghuveer K. Halkar"'
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Purpose 99mTc-tricarbonyl-nitrilotriacetic acid, [99mTc]Tc(CO)3(NTA), is a new 99mTc-renal radiopharmaceutical with a clearance equal to that of 131I-ortho-iodohippuran, [131I]I-OIH. Our purpose was to compare the performance of [99mTc]Tc(CO
Externí odkaz:
https://doaj.org/article/f909ed5c01a64c93abb576929d8986cf
Autor:
Andrew T. Taylor, A.K.M. Fazlur Rahman, Russell D. Folks, Valeria Moncayo, Bital Savir-Baruch, Nicholas Plaxton, Aruna Polsani, Raghuveer K. Halkar, Eva V. Dubovsky, Ernest V. Garcia, Amita Manatunga
Publikováno v:
Nuclear Medicine Communications. 44:427-433
Autor:
Ismaheel O. Lawal, Charles Marcus, David M. Schuster, Subir Goyal, Omotayo A. Adediran, Vishal R. Dhere, Shreyas S. Joshi, Olayinka A. Abiodun-Ojo, Viraj A. Master, Pretesh R. Patel, Bridget Fielder, Mark Goodman, Joseph W. Shelton, Omer Kucuk, Bruce Hershatter, Raghuveer K. Halkar, Ashesh B. Jani
Publikováno v:
Clinical Nuclear Medicine. 48:e153-e159
Autor:
Ismaheel O. Lawal, Ashesh B. Jani, Omotayo A. Adediran, Subir Goyal, Olayinka A. Abiodun-Ojo, Vishal R. Dhere, Charles V. Marcus, Shreyas S. Joshi, Viraj A. Master, Pretesh R. Patel, Mark Goodman, Joseph W. Shelton, Omer Kucuk, Bruce Hershatter, Bridget Fielder, Raghuveer K. Halkar, David M. Schuster
Publikováno v:
Journal of Nuclear Medicine. 64:586-591
Differences in Failure-free Survival Post Salvage Radiotherapy Guided by Conventional Imaging Versus
Autor:
Ismaheel O, Lawal, Ashesh B, Jani, Omotayo A, Adediran, Subir, Goyal, Olayinka A, Abiodun-Ojo, Vishal R, Dhere, Charles V, Marcus, Shreyas S, Joshi, Viraj A, Master, Pretesh R, Patel, Mark, Goodman, Joseph W, Shelton, Omer, Kucuk, Bruce, Hershatter, Bridget, Fielder, Raghuveer K, Halkar, David M, Schuster
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
The EMPIRE-1 (Emory Molecular Prostate Imaging for Radiotherapy Enhancement-1) trial reported a survival advantage in recurrent prostate cancer salvage radiotherapy (SRT) guided by
Purpose 99mTc-tricarbonyl-nitrilotriacetic acid, 99mTc(CO)3(NTA), is a new 99mTc-renal radiopharmaceutical with a clearance equal to that of 131I-ortho-iodohippuran. Our purpose was to compare the performance of 99mTc(CO)3(NTA) and 99mTc-MAG3 in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2123b23414e88ee50e144eec60718457
https://doi.org/10.21203/rs.3.rs-188079/v1
https://doi.org/10.21203/rs.3.rs-188079/v1
Autor:
Olayinka A, Abiodun-Ojo, Ashesh B, Jani, Akinyemi A, Akintayo, Oladunni O, Akin-Akintayo, Oluwaseun A, Odewole, Funmilayo I, Tade, Shreyas S, Joshi, Viraj A, Master, Bridget, Fielder, Raghuveer K, Halkar, Chao, Zhang, Subir, Goyal, Mark M, Goodman, David M, Schuster
Publikováno v:
J Nucl Med
Imaging with novel PET radiotracers has significantly influenced radiotherapy decision making and radiation planning in patients with recurrent prostate cancer (PCa). The purpose of this analysis was to report the final results for management decisio
Autor:
Oluwaseun A, Odewole, Oyeladun A, Oyenuga, Funmilayo, Tade, Bital, Savir-Baruch, Peter T, Nieh, Viraj, Master, Zhengjia, Chen, Xiaojing, Wang, Ashesh B, Jani, Leah M, Bellamy, Raghuveer K, Halkar, Mark M, Goodman, David M, Schuster
Publikováno v:
Molecular imaging and biology. 17(2)
The aim of this study is to examine the reproducibility of anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F]FACBC) quantitative measurements in key background structures and untreated malignant lesions.Retrospective review of
Autor:
Valeria M, Moncayo, Kimberly E, Applegate, Richard, Duszak, Bruce J, Barron, Jim, Fitz, Raghuveer K, Halkar, Daniel J, Lee, David M, Schuster
Publikováno v:
Academic radiology. 22(6)
We developed a longitudinal care coordination service to proactively deliver high-quality and family-centered care in patients receiving radioiodine therapy for thyroid cancer. In an iterative, multidisciplinary team manner, a pretherapy consultation
Autor:
David M, Schuster, Pooneh A, Taleghani, Peter T, Nieh, Viraj A, Master, Rianot, Amzat, Bital, Savir-Baruch, Raghuveer K, Halkar, Tim, Fox, Adeboye O, Osunkoya, Carlos S, Moreno, Jonathon A, Nye, Weiping, Yu, Baowei, Fei, Zhibo, Wang, Zhengjia, Chen, Mark M, Goodman
Publikováno v:
American journal of nuclear medicine and molecular imaging. 3(1)
Anti-1-amino-3-[(18)F] fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) is a synthetic amino acid positron emission tomography (PET) radiotracer with utility in the detection of recurrent prostate carcinoma. The aim of this study is to corr